BackBackEnterprise value to EBITDA ratio of MEDIPLANTEX NATIONAL PHARMACEUTICAL
Annual data
2011
2018
2019
2020
2021
2022
2023
2024
0.00
4.00
8.00
12.00
16.00
Period
Value
Change
Change %
2024
9.90
−4.95
−33.32%
2023
14.85
+7.24
+95.14%
2022
7.61
−1.54
−16.85%
2021
9.15
+3.30
+56.38%
Quarterly data
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
4.50
9.00
13.50
18.00
Period
Value
Change
Change %
Q3 '24
10.85
−1.68
−13.41%
Q2 '24
12.53
+0.45
+3.73%
Q1 '24
12.08
−2.81
−18.87%
Q4 '23
14.89
−1.71
−10.32%
Q3 '23
16.60
+6.44
+63.39%
Q2 '23
10.16
+2.82
+38.52%
Q1 '23
7.33
−2.40
−24.63%